BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29932230)

  • 1. Effects of selenium supplementation on expression of SEPP1 in mRNA and protein levels in subjects with and without metabolic syndrome suffering from coronary artery disease: Selenegene study a double-blind randomized controlled trial.
    Gharipour M; Ouguerram K; Nazih EH; Salehi M; Behmanesh M; Roohafza H; Hosseini SM; Nezafati P; Dianatkhah M; Gharipour A; Haghjoo S; Sarrafzadegan N; Sadeghi M
    J Cell Biochem; 2018 Nov; 119(10):8282-8289. PubMed ID: 29932230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proposal of a study protocol of a preliminary double-blind randomized controlled trial. Verifying effects of selenium supplementation on selenoprotein p and s genes expression in protein and mRNA levels in subjects with coronary artery disease: selenegene.
    Gharipour M; Sadeghi M; Behmanesh M; Salehi M; Roohafza H; Nezafati P; Khosravi E; Hosseini M; Keshvari M; Rouhi-Bourojeni H; Sarrafzadegan N
    Acta Biomed; 2019 Jan; 90(1):44-50. PubMed ID: 30889154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of single nucleotide polymorphisms in SEPS1 and SEPP1 on expression in the protein level in metabolic syndrome in subjects with cardiovascular disease.
    Gharipour M; Ouguerram K; Nazih EH; Salehi M; Behmanesh M; Razavi R; Gharipour A; Diantkhah M; Sadeghi M
    Mol Biol Rep; 2019 Dec; 46(6):5685-5693. PubMed ID: 31542866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of expression of selenoprotein P in mRNA and protein levels with metabolic syndrome in subjects with cardiovascular disease: Results of the Selenegene study.
    Gharipour M; Sadeghi M; Salehi M; Behmanesh M; Khosravi E; Dianatkhah M; Haghjoo Javanmard S; Razavi R; Gharipour A
    J Gene Med; 2017 Mar; 19(3):. PubMed ID: 28190280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic selenoprotein P (SePP) expression restores selenium transport and prevents infertility and motor-incoordination in Sepp-knockout mice.
    Renko K; Werner M; Renner-Müller I; Cooper TG; Yeung CH; Hollenbach B; Scharpf M; Köhrle J; Schomburg L; Schweizer U
    Biochem J; 2008 Feb; 409(3):741-9. PubMed ID: 17961124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative abundance of selenoprotein P isoforms in human plasma depends on genotype, se intake, and cancer status.
    Méplan C; Nicol F; Burtle BT; Crosley LK; Arthur JR; Mathers JC; Hesketh JE
    Antioxid Redox Signal; 2009 Nov; 11(11):2631-40. PubMed ID: 19453253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased Thyroid Peroxidase Antibody Titer in Response to Selenium Supplementation in Autoimmune Thyroiditis and the Influence of a Selenoprotein P Gene Polymorphism: A Prospective, Multicenter Study in China.
    Wang W; Mao J; Zhao J; Lu J; Yan L; Du J; Lu Z; Wang H; Xu M; Bai X; Zhu L; Fan C; Wang H; Zhang H; Shan Z; Teng W
    Thyroid; 2018 Dec; 28(12):1674-1681. PubMed ID: 30398407
    [No Abstract]   [Full Text] [Related]  

  • 8. Optimization of selenoprotein P and other plasma selenium biomarkers for the assessment of the selenium nutritional requirement: a placebo-controlled, double-blind study of selenomethionine supplementation in selenium-deficient Chinese subjects.
    Xia Y; Hill KE; Li P; Xu J; Zhou D; Motley AK; Wang L; Byrne DW; Burk RF
    Am J Clin Nutr; 2010 Sep; 92(3):525-31. PubMed ID: 20573787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma selenoprotein P levels of healthy males in different selenium status after oral supplementation with different forms of selenium.
    Persson-Moschos M; Alfthan G; Akesson B
    Eur J Clin Nutr; 1998 May; 52(5):363-7. PubMed ID: 9630388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishing optimal selenium status: results of a randomized, double-blind, placebo-controlled trial.
    Hurst R; Armah CN; Dainty JR; Hart DJ; Teucher B; Goldson AJ; Broadley MR; Motley AK; Fairweather-Tait SJ
    Am J Clin Nutr; 2010 Apr; 91(4):923-31. PubMed ID: 20181815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic polymorphisms that affect selenium status and response to selenium supplementation in United Kingdom pregnant women.
    Mao J; Vanderlelie JJ; Perkins AV; Redman CW; Ahmadi KR; Rayman MP
    Am J Clin Nutr; 2016 Jan; 103(1):100-6. PubMed ID: 26675765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the human selenoprotein P gene determine the response of selenoprotein markers to selenium supplementation in a gender-specific manner (the SELGEN study).
    Méplan C; Crosley LK; Nicol F; Beckett GJ; Howie AF; Hill KE; Horgan G; Mathers JC; Arthur JR; Hesketh JE
    FASEB J; 2007 Oct; 21(12):3063-74. PubMed ID: 17536041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selenoprotein P genetic variants and mrna expression, circulating selenium, and prostate cancer risk and survival.
    Penney KL; Li H; Mucci LA; Loda M; Sesso HD; Stampfer MJ; Ma J
    Prostate; 2013 May; 73(7):700-5. PubMed ID: 23129481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized trial of selenium supplementation and risk of type-2 diabetes, as assessed by plasma adiponectin.
    Rayman MP; Blundell-Pound G; Pastor-Barriuso R; Guallar E; Steinbrenner H; Stranges S
    PLoS One; 2012; 7(9):e45269. PubMed ID: 23028897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selenium and its relationship with selenoprotein P and glutathione peroxidase in children and adolescents with Hashimoto's thyroiditis and hypothyroidism.
    Nourbakhsh M; Ahmadpour F; Chahardoli B; Malekpour-Dehkordi Z; Nourbakhsh M; Hosseini-Fard SR; Doustimotlagh A; Golestani A; Razzaghy-Azar M
    J Trace Elem Med Biol; 2016 Mar; 34():10-4. PubMed ID: 26854239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selenium deficiency occurs in some patients with moderate-to-severe cirrhosis and can be corrected by administration of selenate but not selenomethionine: a randomized controlled trial.
    Burk RF; Hill KE; Motley AK; Byrne DW; Norsworthy BK
    Am J Clin Nutr; 2015 Nov; 102(5):1126-33. PubMed ID: 26468123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diverse Associations of Plasma Selenium Concentrations and SELENOP Gene Polymorphism with Metabolic Syndrome and Its Components.
    Zhou L; Luo C; Yin J; Zhu Y; Li P; Chen S; Sun T; Xie M; Shan Z; Cao B; Hu X; Rong Y; Yang W; Li X; Tan A; Liu L
    Oxid Med Cell Longev; 2020; 2020():5343014. PubMed ID: 32377302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression profiling and genetic alterations of the selenoproteins GI-GPx and SePP in colorectal carcinogenesis.
    Al-Taie OH; Uceyler N; Eubner U; Jakob F; Mörk H; Scheurlen M; Brigelius-Flohe R; Schöttker K; Abel J; Thalheimer A; Katzenberger T; Illert B; Melcher R; Köhrle J
    Nutr Cancer; 2004; 48(1):6-14. PubMed ID: 15203372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Folate Supplementation on Carotid Intima-Media Thickness and Metabolic Status in Patients with Metabolic Syndrome.
    Talari HR; Rafiee M; Farrokhian A; Raygan F; Bahmani F; Darooghegi Mofrad M; Hamidian Y; Tamtaji OR; Karamali F; Asemi Z
    Ann Nutr Metab; 2016; 69(1):41-50. PubMed ID: 27450552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selenium Supplementation Affects Insulin Resistance and Serum hs-CRP in Patients with Type 2 Diabetes and Coronary Heart Disease.
    Farrokhian A; Bahmani F; Taghizadeh M; Mirhashemi SM; Aarabi MH; Raygan F; Aghadavod E; Asemi Z
    Horm Metab Res; 2016 Apr; 48(4):263-8. PubMed ID: 26743526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.